Skip to content
healthcare.dev

Digoxin

NDC 10135-747, Digoxin, tablet, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-747
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215307
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-747 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIGOXIN.125 mg/1

Pharmacologic classes

Cardiac Glycoside [EPC]; Cardiac Glycosides [CS]

Package NDCNDC-11Package
10135-747-0110135074701100 TABLET in 1 BOTTLE (10135-747-01)
10135-747-10101350747101000 TABLET in 1 BOTTLE (10135-747-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e104c3c5-e4b8-7dbd-e053-2995a90ae339

Use it

Look up 10135-747 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-747 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-747. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.